The absorption, distribution, metabolism and elimination of bevirimat in rats

Biopharm Drug Dispos. 2008 Oct;29(7):396-405. doi: 10.1002/bdd.625.

Abstract

Bevirimat is the first drug in the class of maturation inhibitors, which treat HIV infection by disrupting the activity of HIV protease enzyme with a mechanism of action distinct from that of conventional protease inhibitors. The absorption, distribution, metabolism and elimination characteristics of single intravenous (25 mg/kg) and oral (25 mg/kg and 600 mg/kg) doses of 14C-bevirimat were studied in male Sprague Dawley and Long Evans rats. Pharmacokinetic and mass-balance studies revealed that bevirimat was cleared rapidly (within 12-24 h) after dosing, although plasma radioactivity was quantifiable up to 168 h. Radioactive metabolites of bevirimat were responsible for approximately 60-80% of plasma radioactivity. Systemically available bevirimat was predominantly (97%) excreted via bile in the faeces, with <or=1% of the dose excreted renally. Less than 0.1% of the dose was excreted in expired air. Quantitative whole-body autoradiography detected high quantities of radioactivity in the bile and liver soon after intravenous dose administration, and evidence of biliary excretion present during the 8 h following oral dosing. Oral bioavailability for the 25 mg/kg dose of bevirimat was estimated at 22-24% by pharmacokinetic and mass-balance methods, with bioavailability decreasing disproportionately with increasing dose for the 600 mg/kg group.

MeSH terms

  • Administration, Oral
  • Animals
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / pharmacokinetics*
  • Autoradiography
  • Bile / metabolism
  • Biological Availability
  • Dose-Response Relationship, Drug
  • Feces / chemistry
  • HIV Infections / drug therapy
  • Injections, Intravenous
  • Male
  • Rats
  • Rats, Long-Evans
  • Rats, Sprague-Dawley
  • Succinates / administration & dosage
  • Succinates / pharmacokinetics*
  • Triterpenes / administration & dosage
  • Triterpenes / pharmacokinetics*

Substances

  • Anti-HIV Agents
  • Succinates
  • Triterpenes
  • bevirimat